Coming off TRT: what the recovery science actually shows

What did @jeremygoodmanmd actually say?

The claim here is fairly specific: men who started TRT while still producing some testosterone on their own can recover natural production by running HCG at 500-1,000 IU two to three times weekly for two to six weeks, then following up with a SERM like clomiphene or tamoxifen for another two to eight weeks. He also warned that using HCG too long causes desensitization. The protocol is explicitly framed as not applying to men with primary hypogonadism who were already making little to no testosterone before starting.

That's a more careful setup than most TRT recovery content on TikTok. The carve-out for men who "make 100" (presumably 100 ng/dL or less before TRT) is clinically relevant, and the disclaimer that this is for people who "jumped on TRT a little too early" reflects actual clinical nuance. Whether the specific numbers hold up to scrutiny is a different question.

Does the science back this up?

The general framework is supported by endocrine literature, though the evidence base is thinner than most people assume. HCG stimulates Leydig cells directly via LH receptor agonism, which can restore intratesticular testosterone and restart spermatogenesis after exogenous androgen suppression. SERMs like clomiphene work upstream by blocking estrogen receptors in the hypothalamus and pituitary, increasing endogenous LH and FSH output.

A 2013 study by Wenker et al. in Fertility and Sterility showed clomiphene citrate effectively restored testosterone and sperm parameters in men with secondary hypogonadism, and smaller case series support its use post-TRT. The concern about HCG-induced Leydig cell desensitization with prolonged use is documented in reproductive medicine literature, including work by Rowe and colleagues. However, most of the evidence comes from fertility medicine and anabolic steroid recovery contexts, not from well-designed randomized controlled trials specifically in TRT patients. The two-to-six-week HCG window he recommends is reasonable but not universally agreed upon.

What did they get wrong (or right)?

He got the directional logic right. Using HCG before a SERM makes biological sense because you want to prime Leydig cells before switching to upstream signaling. Running them sequentially rather than simultaneously is a defensible approach, and the desensitization warning about prolonged HCG use is real and often left out of social media protocols.

What's missing is meaningful. He doesn't address the role of baseline LH and FSH testing before attempting recovery, which is how you actually determine whether someone has secondary versus primary hypogonadism. He also doesn't mention that recovery timelines are highly variable. A 2020 review by Patel et al. in the World Journal of Men's Health found that spermatogenesis recovery after TRT could take six to eighteen months, sometimes longer, depending on duration of use and baseline function. Framing the SERM window as "two to eight weeks" without context could give men unrealistic expectations. The phrase "bring back the boys" refers to testicular function but conflates fertility recovery with testosterone recovery, which don't always follow the same timeline.

What should you actually know?

If you've been on TRT and want to come off, the pathway depends entirely on why you went on in the first place. Men with documented secondary hypogonadism (where the problem is in the pituitary or hypothalamus, not the testes) are the best candidates for recovery protocols like this one. Men with primary hypogonadism are not, and running HCG and SERMs on a testis that never worked won't change that outcome.

Before starting any recovery attempt, you need baseline labs: total testosterone, LH, FSH, and ideally a semen analysis if fertility matters to you. The Endocrine Society's clinical practice guidelines on male hypogonadism emphasize proper diagnostic workup before and during any intervention. HCG is not approved by the FDA for this specific use in men, and tamoxifen's use in this context is off-label. That doesn't make it wrong, but it means your prescriber needs to know what they're doing and monitor accordingly. Clomiphene and tamoxifen are not interchangeable in practice even if they're both SERMs. Recovery is possible for the right patient. It's not guaranteed for anyone.